⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL415976 | 0.93 | — | — | |
| Bromide SCHEMBL27282327 | 0.86 | — | — | |
| Ethane SCHEMBL2433111 | 0.80 | — | — | |
| Cyclopropane SCHEMBL27527299 | 0.76 | — | — | |
| Benzene SCHEMBL2329769 | 0.76 | HTR6 (0.35) | — | |
| SCHEMBL9722581 | 0.76 | — | — | |
| Methane SCHEMBL11777323 | 0.76 | — | — | |
| Ethane SCHEMBL27881114 | 0.76 | KDM4E (0.36) | — | |
| Chloromethane SCHEMBL27606445 | 0.76 | — | — | |
| Chloroform SCHEMBL11337501 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250129039-A1 | NOVEL PROCESS FOR THE PREPARATION OF BILASTINE AND INTERMEDIATES THEREOF | BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. (IN) | 2025-04-24 | — | — | US | claimed |
| WO-2023037184-A2 | NOVEL PROCESS FOR THE PREPARATION OF BILASTINE AND INTERMEDIATES THEREOF | BIOPHORE INDIA PHARMACEUTICALS PVT. LTD (IN) | 2023-03-16 | — | — | WO | claimed |
| US-20220017650-A1 | NOVEL PROCESS FOR THE PURIFICATION OF SUGAMMADEX SODIUM | BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. (IN) | 2022-01-20 | — | — | US | claimed |
| WO-2020121207-A1 | NOVEL PROCESS FOR THE PURIFICATION OF SUGAMMADEX SODIUM | BIOPHORE INDIA PHARMACEUTICALS PVT. LTD (IN) | 2020-06-18 | — | — | WO | claimed |
| EP-2560955-B1 | NOVEL BENZAMIDE DERIVATIVES | DONG A PHARM CO LTD (KR) | 2016-06-29 | — | — | EP | claimed |
| US-9221790-B2 | Benzamide derivatives | DONG-A PHARM. CO., LTD. (KR) | 2015-12-29 | — | — | US | claimed |
| US-20130085160-A1 | NOVEL BENZAMIDE DERIVATIVES | DONG-A PHARM. CO., LTD. (KR) | 2013-04-04 | — | — | US | claimed |
| EP-2560955-A2 | NOVEL BENZAMIDE DERIVATIVES | Dong-A Pharm.Co., Ltd. (KR) | 2013-02-27 | — | — | EP | claimed |
| WO-2012004658-A2 | PROCESS FOR PREPARATION OF N-[2-BUTYL-3-[4-[3-(DIBUTYLAMINO)PROPOXY]BENZOYL]-5-BENZOFURANYL]METHANESULFONAMIDE, ACID ADDITION SALTS AND PRODUCT THEREOF | FRICHEM PRIVATE LIMITED (IN) | 2012-01-12 | — | — | WO | claimed |
| WO-2011132901-A2 | NOVEL BENZAMIDE DERIVATIVES | DONG-A PHARM.CO., LTD. (KR) | 2011-10-27 | — | — | WO | claimed |
| US-5384419-A | Preparation process for 20-keto-21(S) hydroxy steroid compounds and intermediates | ROUSSEL-UCLAF (FR) | 1995-01-24 | — | — | US | claimed |
| US-20250129039-A1 | NOVEL PROCESS FOR THE PREPARATION OF BILASTINE AND INTERMEDIATES THEREOF | BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. (IN) | 2025-04-24 | — | — | US | disclosed |
| WO-2023037184-A2 | NOVEL PROCESS FOR THE PREPARATION OF BILASTINE AND INTERMEDIATES THEREOF | BIOPHORE INDIA PHARMACEUTICALS PVT. LTD (IN) | 2023-03-16 | — | — | WO | disclosed |
| US-20220017650-A1 | NOVEL PROCESS FOR THE PURIFICATION OF SUGAMMADEX SODIUM | BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. (IN) | 2022-01-20 | — | — | US | disclosed |
| WO-2020121207-A1 | NOVEL PROCESS FOR THE PURIFICATION OF SUGAMMADEX SODIUM | BIOPHORE INDIA PHARMACEUTICALS PVT. LTD (IN) | 2020-06-18 | — | — | WO | disclosed |
| US-4287342-A | 2,4,6-Trihalo-5-alkyl-and 5-alkenylsulphonylpyrimidines | CIBA-GEIGY CORPORATION (US) | 1981-09-01 | — | — | US | disclosed |
| US-4188483-A | 5-Alkylsulphonyl- and 5-alkenylsulphonylbarbituric acids and derivatives thereof | CIBA-GEIGY CORPORATION (US) | 1980-02-12 | — | — | US | disclosed |
| US-4089865-A | Certain thiazole compounds | SYNTEX (U.S.A.) INC. (US) | 1978-05-16 | — | — | US | disclosed |
| US-4001421-A | THIAZOLE CARDIOVASCULAR AGENTS | SYNTEX (U.S.A.) INC. (US) | 1977-01-04 | — | — | US | disclosed |
| US-3982010-A | Thiazole cardiovascular agents | SYNTEX (U.S.A.) INC. (US) | 1976-09-21 | — | — | US | disclosed |